Research of neopeptides/neoproteins in prostate cancer cell lines
Ontology highlight
ABSTRACT: Validation, by mass spectrometry (MS), of predicted neoantigens in urinary extracellular vesicles coming from cancer prostate patients. We performed MS on PC3, LNCaP and HCT116 cells and compared MS-detected peptides with established PC3 lncRNA peptides, peptides from lncRNAs upregulated in uEVs and Swiss prot databanks.
INSTRUMENT(S): Orbitrap Exploris 480
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Colorectal Cancer Cell Line, Prostate Cancer Cell Line
SUBMITTER: Victor Laigle
LAB HEAD: Damarys Loew
PROVIDER: PXD032264 | Pride | 2022-05-31
REPOSITORIES: Pride
ACCESS DATA